Prulifloxacin
Especificaciones
123447-62-1Número CAS
819-932-1Número CE
6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acidNombre IUPAC
C21H20FN3O6SFórmula química
461.5 g/molPeso molecular
Prulifloxacin; 123447-62-1; NM441; Pruvel; NM-441; Sword; NM 441; DTXSID0046480; prulifloxacine; prulifloxacino; J42298IESW; NSC-759833; 1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-; DTXCID8026480; 1H,4H-(1,3)Thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo-; prulifloxacinum; RefChem:176763; J01MA17; 6-fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid; (RS)-6-Fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid; Prulifloxacin [INN]; 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid; 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid; MFCD00864847; Prulifloxacin (hydrochloride); Quisnon; NCGC00164615-01; 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid; CCRIS 7686; CAS-123447-62-1; UNII-J42298IESW; PWNMXPDKBYZCOO-UHFFFAOYSA-N; Prulifloxacin (Pruvel); Prulifloxacin (Standard); PRULIFLOXACIN [MI]; PRULIFLOXACIN [JAN]; MLS006011767; PRULIFLOXACIN [MART.]; PRULIFLOXACIN [WHO-DD]; CHEMBL422648; NAD-441A; OPT-99; orb1221008; orb1301827; SCHEMBL1650794; SCHEMBL29540773; CHEBI:32071; GTPL12860; HY-B0024R; MSK5749; GLXC-06577; HMS5080A06; HY-B0024; Tox21_112235; s2071; STK626148; AKOS005559236; NM441;AF 3013; Prulifloxacin (NM441, AF 3013); Tox21_112235_1; AC-2012; AP27249; DB11892; NSC 759833; SB18983; NCGC00164615-02; NCGC00164615-03; (+-)-7-(4-((Z)-2,3-Dihydroxy-2-butenyl)-1-piperazinyl)-6-fluoro-1-methyl-4-oxo-1H,4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid, cyclic carbonate; 6-FLUORO-1-METHYL-7-{4-[(5-METHYL-2-OXO-2H-1,3-DIOXOL-4-YL)METHYL]PIPERAZIN-1-YL}-4-OXO-1H,4H-[1,3]THIAZETO[3,2-A]QUINOLINE-3-CARBOXYLIC ACID; AS-13607; SMR000046722; Prulifloxacin 100 |Ig/mL in Acetonitrile; NS00068018; P2058; P7082; Prulifloxacin 100 microg/mL in Acetonitrile; T5394; F20576; SBI-0653843.0001; F876131; Prulifloxacin, >=98% (perchloric acid titration); SR-01000872596; Q3924793; SR-01000872596-1; BRD-A92341659-001-01-6; BRD-A92341659-001-03-2; BRD-A92341659-001-04-0; 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-13-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1H4H-[13]thiazeto[32-a]quinoline-3-carboxylic acid; 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-4-ium-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate; 6-fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acidSinónimos
